{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:37:52Z","timestamp":1747204672576,"version":"3.40.5"},"posted":{"date-parts":[[2023,6,12]]},"group-title":"In Review","reference-count":22,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,5,18]]},"abstract":"<title>Abstract<\/title>\n        <p>Purpose\n Lymph node(LN) dissection is part of most oncologic resections. Intraoperatively identifying a positive LN(+\u2009LN), that harbors malignant cells, can be challenging. We hypothesized that intraoperative molecular imaging(IMI) using a cancer-targeted fluorescent prober can identify\u2009+\u2009LNs. This study aimed to develop a preclinical model of a\u2009+\u2009LN and test it using an activatable cathepsin-based enzymatic probe, VGT-309.\nProcedures\n In the first model, we used peripheral blood mononuclear cells (PBMC), representing the lymphocytic composition of the LN, mixed with different concentrations of human lung adenocarcinoma cell line A549. Then, they were embedded in a Matrigel\u00ae matrix. A black dye was added to mimic LN anthracosis. Model two was created using a murine spleen, the largest lymphoid organ, injected with various concentrations of A549. To test these models, we co-cultured A549 cells with VGT-309. Mean fluorescence intensity(MFI) was. An independent sample t-test was used to compare the average MFI of each A549:negative control ratio.\nResults\n A significant difference in MFI from our PBMC control was noted when A549 cells were 25% of the LN (p\u2009=\u20090.046) in both 3D cell aggregate models-where the LNs native parenchyma is replaced and the one where the tumor grows over the native parenchyma. For the anthracitic equivalents of these models, the first significant MFI compared to the control was when A549 cells were 9% of the LN (p\u2009=\u20090.002) in the former model, and 16.7% of the LN (p\u2009=\u20090.033) in the latter. In our spleen model, we first noted significance in MFI when A549 cells were 16.67% of the cellular composition.(p\u2009=\u20090.02)\nConclusions\n A\u2009+\u2009LN model allows for a granular evaluation of different cellular burdens in +\u2009LN that can be assessed using IMI. This first exvivo\u2009+\u2009LN model can be used in preclinical testing of several existing dyes and in creating more sensitive cameras for IMI-guided LN detection.<\/p>","DOI":"10.21203\/rs.3.rs-2953015\/v1","type":"posted-content","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T17:28:25Z","timestamp":1686590905000},"source":"Crossref","is-referenced-by-count":0,"title":["Preclinical Lymph Node Model for Intraoperative Molecular Imaging of Cancer"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6397-5644","authenticated-orcid":false,"given":"Patrick","family":"Bou-Samra","sequence":"first","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin","family":"Chang","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachinthani","family":"Arambepola","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Guo","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feredun","family":"Azari","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Kennedy","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alix","family":"Segil","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2413-7082","authenticated-orcid":false,"given":"Sunil","family":"Singhal","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"5","key":"ref1","first-page":"497","article-title":"I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894","volume":"1894","author":"Halsted WS","unstructured":"Halsted WS I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. Ann Surg, 1894. 20(5): p. 497\u2013555","journal-title":"Ann Surg"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1245\/ASO.2003.03.058","article-title":"The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined","volume":"10","author":"Swanson RS","year":"2003","unstructured":"Swanson RS et al (2003) The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10(1):65\u201371","journal-title":"Ann Surg Oncol"},{"issue":"23","key":"ref3","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1200\/JCO.2011.40.3519","article-title":"Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline","volume":"30","author":"Wong SL","year":"2012","unstructured":"Wong SL et al (2012) Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. J Clin Oncol 30(23):2912\u20132918","journal-title":"J Clin Oncol"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","DOI":"10.1097\/01.sla.0000086543.45557.cb","article-title":"Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases","volume":"238","author":"Morton DL","year":"2003","unstructured":"Morton DL et al (2003) Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg, 238(4): p. 538 \u2013 49; discussion 549 \u2013 50.","journal-title":"Ann Surg"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.lungcan.2010.02.009","article-title":"Subcarinal lymph node in upper lobe non-small cell lung cancer patients: is selective lymph node dissection valid?","volume":"70","author":"Aokage K","year":"2010","unstructured":"Aokage K et al (2010) Subcarinal lymph node in upper lobe non-small cell lung cancer patients: is selective lymph node dissection valid? Lung Cancer 70(2):163\u2013167","journal-title":"Lung Cancer"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.athoracsur.2017.02.074","article-title":"Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer","volume":"104","author":"Ghaly G","year":"2017","unstructured":"Ghaly G et al (2017) Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer. Ann Thorac Surg 104(4):1153\u20131158","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ejcts.2006.08.008","article-title":"ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer","volume":"30","author":"Lardinois D","year":"2006","unstructured":"Lardinois D et al (2006) ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 30(5):787\u2013792","journal-title":"Eur J Cardiothorac Surg"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"e78552","DOI":"10.1371\/journal.pone.0078552","article-title":"Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of \u00b9\u00e2\u0081\u00b8F-FDG PET\/CT","volume":"8","author":"Li S","year":"2013","unstructured":"Li S et al (2013) Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of \u00b9\u00e2\u0081\u00b8F-FDG PET\/CT. PLoS ONE 8(10):e78552","journal-title":"PLoS ONE"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.21037\/jtd-22-1100","article-title":"Intraoperative molecular imaging in thoracic oncology: pushing the boundaries of precision resection for occult non-small cell lung cancer in the era of minimally invasive surgery","volume":"14","author":"Azari F","year":"2022","unstructured":"Azari F et al (2022) Intraoperative molecular imaging in thoracic oncology: pushing the boundaries of precision resection for occult non-small cell lung cancer in the era of minimally invasive surgery. J Thorac Dis 14(10):3688\u20133691","journal-title":"J Thorac Dis"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1535-6108(04)00111-4","article-title":"Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis","volume":"5","author":"Joyce JA","year":"2004","unstructured":"Joyce JA et al (2004) Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 5(5):443\u2013453","journal-title":"Cancer Cell"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2007.10.011","article-title":"Cysteine cathepsin proteases as pharmacological targets in cancer","volume":"29","author":"Palermo C","year":"2008","unstructured":"Palermo C, Joyce JA (2008) Cysteine cathepsin proteases as pharmacological targets in cancer. Trends Pharmacol Sci 29(1):22\u201328","journal-title":"Trends Pharmacol Sci"},{"year":"2022","author":"Kennedy GT","key":"ref12","unstructured":"Kennedy GT et al (2022) Preclinical Evaluation of an Activity-Based Probe for Intraoperative Imaging of Esophageal Cancer. Mol Imaging, 2022: p.\u00a05447290"},{"issue":"17","key":"ref13","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1158\/1078-0432.CCR-22-1215","article-title":"A Cathepsin-Targeted Quenched Activity-Based Probe Facilitates Enhanced Detection of Human Tumors during Resection","volume":"28","author":"Kennedy GT","year":"2022","unstructured":"Kennedy GT et al (2022) A Cathepsin-Targeted Quenched Activity-Based Probe Facilitates Enhanced Detection of Human Tumors during Resection. Clin Cancer Res 28(17):3729\u20133741","journal-title":"Clin Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/aja.1001100303","article-title":"The reticulum of lymph nodes in mice studied with the electron microscope","volume":"110","author":"Clark SL","year":"1962","unstructured":"Clark SL Jr (1962) The reticulum of lymph nodes in mice studied with the electron microscope. Am J Anat 110:217\u2013257","journal-title":"Am J Anat"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.urology.2021.09.010","article-title":"Parenchymal Volume Replacement by Renal Cell Carcinoma Prior to Intervention: Predictive Factors and Functional Implications","volume":"159","author":"Palacios DA","year":"2022","unstructured":"Palacios DA et al (2022) Parenchymal Volume Replacement by Renal Cell Carcinoma Prior to Intervention: Predictive Factors and Functional Implications. Urology 159:139\u2013145","journal-title":"Urology"},{"key":"ref16","volume-title":"Thurlbeck's pathology of the lung","author":"Myers JL","year":"2005","unstructured":"Myers JL, Tazelaar HD, LMDFRCP J (2005) Thurlbeck's pathology of the lung. Thieme, New York"},{"issue":"17","key":"ref17","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1158\/1078-0432.CCR-22-1215","article-title":"A Cathepsin-Targeted Quenched Activity\u2013Based Probe Facilitates Enhanced Detection of Human Tumors during Resection","volume":"28","author":"Kennedy GT","year":"2022","unstructured":"Kennedy GT et al (2022) A Cathepsin-Targeted Quenched Activity\u2013Based Probe Facilitates Enhanced Detection of Human Tumors during Resection. Clin Cancer Res 28(17):3729\u20133741","journal-title":"Clin Cancer Res"},{"issue":"4","key":"ref18","first-page":"1","article-title":"Anthracosis of the lungs: etiology, clinical manifestations and diagnosis: a review","volume":"13","author":"Mirsadraee M","year":"2014","unstructured":"Mirsadraee M (2014) Anthracosis of the lungs: etiology, clinical manifestations and diagnosis: a review. Tanaffos 13(4):1\u201313","journal-title":"Tanaffos"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/138920010791636149","article-title":"Specific hemosiderin deposition in spleen induced by a low dose of cisplatin: altered iron metabolism and its implication as an acute hemosiderin formation model","volume":"11","author":"Wang Y","year":"2010","unstructured":"Wang Y et al (2010) Specific hemosiderin deposition in spleen induced by a low dose of cisplatin: altered iron metabolism and its implication as an acute hemosiderin formation model. Curr Drug Metab 11(6):507\u2013515","journal-title":"Curr Drug Metab"},{"issue":"9 Suppl","key":"ref20","first-page":"13s","article-title":"Current practice and future directions in pathology and laboratory evaluation of the sentinel node","volume":"8","author":"Cochran AJ","year":"2001","unstructured":"Cochran AJ et al (2001) Current practice and future directions in pathology and laboratory evaluation of the sentinel node. Ann Surg Oncol 8(9 Suppl):13s\u201317s","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.pas.0000152134.36030.b7","article-title":"Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis","volume":"29","author":"Spanknebel K","year":"2005","unstructured":"Spanknebel K et al (2005) Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol 29(3):305\u2013317","journal-title":"Am J Surg Pathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.2147\/JIR.S375250","article-title":"Macrophage-Specific Cathepsin as a Marker Correlated with Prognosis and Tumor Microenvironmental Characteristics of Clear Cell Renal Cell Carcinoma","volume":"15","author":"Zhang F","year":"2022","unstructured":"Zhang F et al (2022) Macrophage-Specific Cathepsin as a Marker Correlated with Prognosis and Tumor Microenvironmental Characteristics of Clear Cell Renal Cell Carcinoma. J Inflamm Res 15:6275\u20136292","journal-title":"J Inflamm Res"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2953015\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2953015\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T20:39:28Z","timestamp":1693773568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2953015\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":22,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2953015\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,6,12]]},"subtype":"preprint"}}